van Schaik Malene Vera, Pasman H Roeline, Widdershoven Guy, Metselaar Suzanne
Department of Ethics, Law and Humanities, Amsterdam UMC, VU University, Amsterdam, The Netherlands.
Department of Public and Occupational Health, Expertise Center for Palliative Care, Amsterdam UMC, VU University, Amsterdam, The Netherlands.
BMC Med Ethics. 2022 Mar 23;23(1):32. doi: 10.1186/s12910-022-00772-1.
Existing clinical ethics support (CES) instruments are considered useful. However, users report obstacles in using them in daily practice. Including end users and other stakeholders in developing CES instruments might help to overcome these limitations. This study describes the development process of a new ethics support instrument called CURA, a low-threshold four-step instrument focused on nurses and nurse assistants working in palliative care.
We used a participatory development design. We worked together with stakeholders in a Community of Practice throughout the study. Potential end users (nurses and nurse assistants in palliative care) used CURA in several pilots and provided us with feedback which we used to improve CURA.
We distinguished three phases in the development process. Phase one, Identifying Needs, focused on identifying stakeholder and end user needs and preferences, learning from existing CES instruments, their development and evaluation, and identify gaps. Phase two, Development, focused on designing, developing, refining and tailoring the instrument on the basis of iterative co-creation. Phase three, Dissemination, focused on implementation and dissemination. The instrument, CURA, is a four-step low-threshold instrument that fosters ethical reflection.
Participatory development is a valuable approach for developing clinical ethics support instruments. Collaborating with end users and other stakeholders in our development study has helped to meet the needs and preferences of end users, to come up with strategies to refine the instrument in order to enhance its feasibility, and to overcome reported limitations of existing clinical ethics instruments.
现有的临床伦理支持(CES)工具被认为是有用的。然而,用户报告在日常实践中使用这些工具存在障碍。让终端用户和其他利益相关者参与临床伦理支持工具的开发可能有助于克服这些限制。本研究描述了一种名为CURA的新型伦理支持工具的开发过程,这是一种低门槛的四步工具,主要针对从事姑息治疗的护士和护理助理。
我们采用了参与式开发设计。在整个研究过程中,我们与实践社区中的利益相关者合作。潜在的终端用户(姑息治疗中的护士和护理助理)在几次试点中使用了CURA,并向我们提供反馈,我们利用这些反馈来改进CURA。
我们在开发过程中区分出三个阶段。第一阶段,识别需求,重点是识别利益相关者和终端用户的需求与偏好,借鉴现有的临床伦理支持工具及其开发和评估经验,并找出差距。第二阶段,开发,重点是在迭代共创的基础上设计、开发、完善和定制该工具。第三阶段,传播,重点是实施和推广。该工具CURA是一个四步低门槛工具,可促进伦理反思。
参与式开发是开发临床伦理支持工具的一种有价值的方法。在我们的开发研究中与终端用户和其他利益相关者合作有助于满足终端用户的需求和偏好,提出完善该工具的策略以提高其可行性,并克服现有临床伦理工具所报告的局限性。